Sonya Del Tredici and John Keenan
Sonya Del Tredici and John Keenan
25. High-dose Buprenorphine Induction
25. High-dose Buprenorphine Induction
25. High-dose Buprenorphine Induction
Monday 17th July 2023
Join Drs. Del Tredici and Keenan as they explore high-dose buprenorphine induction and its promising implications for opioid use disorder treatment.
31 minutes
Informative
Hopeful
Empowering
Inspiring
Supportive
About this podcast
Author:
Sonya Del Tredici and John Keenan
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Navigating Intimate Relationships
Family Recovery from Addiction
Nutritional Pathways to Recovery
Episodes:
56 (View all)
Do you want to link to this podcast?
Get the buttons here!Breaking Down High-Dose Buprenorphine: Insights for Addiction Medicine
Episode Overview
- The study revealed low incidence of precipitated withdrawal and no serious adverse events related to buprenorphine administration
- There was a noticeable shift towards favouring the higher dose protocol as the trial progressed
- The findings offer insights into the safety and effectiveness of high-dose buprenorphine inductions for patients with opioid use disorder
- The study's implications extend beyond the emergency department, potentially impacting outpatient and inpatient settings
- The discussion sheds light on the evolving landscape of addiction medicine practices
Initiation of buprenorphine for the treatment of opioid use disorder in the emergency department combined with linkage to outpatient care is an effective strategy to reduce morbidity and mortality among persons living with opioid addiction.
Ever wondered about the latest advancements in addiction treatment? This episode of 'Addiction Medicine Journal Club' has got you covered. Dr. Sonia Del Tredici and Dr. John Keenan dive into a groundbreaking 2018 study on high-dose buprenorphine induction, shedding light on its promising results in emergency departments. The study, which focused on treating opioid use disorder, found that high doses could be administered with minimal risk of precipitated withdrawal and no serious adverse effects.
This shift towards higher doses during the trial suggests a potential game-changer for both outpatient and inpatient care settings. Whether you're a healthcare professional or someone interested in the latest research, this episode offers valuable insights into how high-dose buprenorphine can make a significant difference in addiction treatment. Tune in to hear Drs. Del Tredici and Keenan discuss the practical applications of this study and what it means for the future of addiction medicine.